Cite
HARVARD Citation
Winston, A. et al. (2017). Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir–Ritonavir Plus Either Raltegravir or Tenofovir–Emtricitabine. Journal of acquired immune deficiency syndromes. p. . [Online].